Please login to the form below

Not currently logged in
Email:
Password:

Novartis cuts 550 sales jobs

Swiss company Novartis has announced that 550 posts in its US salesforce will be lost as part of a restructure

Swiss company Novartis has announced that 550 posts in its US salesforce will be lost as part of a restructure.

Novartis plans to better address the differences in local market dynamics through the implementation of a new programme, Customer Centric Initiative. Five cross-functional regional units will replace the current nationally managed salesforces.

As a result, 550 full-time equivalent posts will be lost. However, Novartis claims that more than half of these posts are currently vacant and will be cut without being filled. It is anticipated that by 2010 these changes will result in annual savings of $80m.

The company has also announced changes to its management structure with the appointment of Dr Joerg Reinhardt as the new CEO. He will report to Dr Daniel Vasella, chairman and CEO, whose contract has been extended.

This announcement was made at the same time as Novartis reported a rise in net profit and a 12 per cent increase in net sales to $31.4bn.

Commenting on the results, Dr Daniel Vasella, chairman and CEO of Novartis said: "Despite the economic uncertainty in the world markets, Novartis is on track for another year of record results in 2008, continuing to build momentum by focusing on innovation and performance."

20th October 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics